{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for penicillin root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
NCT03817424: Phase 1 Interventional Completed Systemic Lupus Erythematosus
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mazorelvimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04386616: Phase 2 Interventional Completed COVID-19 Pneumonia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03478488: Phase 3 Interventional Active, not recruiting Biliary Tract Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04524455: Phase 1 Interventional Completed Acute Lymphoblastic Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03384745: Phase 2 Interventional Completed Psoriasis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03792841: Phase 1 Interventional Completed Metastatic Castration-resistant Prostate Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03541369: Phase 1 Interventional Terminated Relapsed/Refractory Acute Myeloid Leukemia (AML)
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:runimotamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03224819: Early Phase 1 Interventional Terminated Acute Myeloid Leukemia
(2017)
Source URL:
Class:
PROTEIN
